FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2122507029> ?p ?o ?g. }

• W2122507029 endingPage "2154" @default.
• W2122507029 startingPage "2146" @default.
• W2122507029 abstract "To explore the changes in serologic variables and clinical disease activity following B lymphocyte depletion in 22 patients with rheumatoid arthritis (RA).B lymphocyte depletion was attained using combination therapy based on the monoclonal anti-CD20 antibody rituximab. Levels of a serologic indicator of inflammation, C-reactive protein (CRP), of antimicrobial antibodies, of autoantibodies including IgA-, IgM-, and IgG-class rheumatoid factors (RF), and of antibodies to cyclic citrullinated peptide (anti-CCP) were assayed.The majority of patients showed a marked clinical improvement after treatment with rituximab, with benefit lasting up to 33 months. Levels of total serum immunoglobulins fell, although the mean values each remained within the normal range. Whereas the IgM-RF response paralleled the changes in total serum IgM levels, the levels of IgA-RF, IgG-RF, and IgG and anti-CCP antibodies decreased significantly more than did those of their corresponding total serum immunoglobulin classes. The kinetics for the reduction in CRP levels also paralleled the decreases in autoantibody levels. In contrast, levels of antimicrobial antibodies did not change significantly. B lymphocyte return occurred up to 21 months posttreatment. The time to relapse after B lymphocyte return was often long and unpredictable (range 0-17 months). Relapse was, however, closely correlated with rises in the level of at least one autoantibody. Increased autoantibody levels were rarely observed in the absence of clinical change.Following B lymphocyte depletion in patients with RA, a positive clinical response occurred in correlation with a significant drop in the levels of CRP and autoantibodies. Antibacterial antibody levels were relatively well maintained. B lymphocyte return preceded relapse in all patients. There was also a temporal relationship between clinical relapse and rises in autoantibody levels. Although these observations are consistent with a role for B lymphocytes in the pathogenesis of RA, the precise mechanisms involved remain unclear." @default.
• W2122507029 created "2016-06-24" @default.
• W2122507029 creator A5014392818 @default.
• W2122507029 creator A5034270145 @default.
• W2122507029 creator A5050093551 @default.
• W2122507029 creator A5051594487 @default.
• W2122507029 creator A5051697835 @default.
• W2122507029 creator A5072708850 @default.
• W2122507029 creator A5082185560 @default.
• W2122507029 date "2003-08-01" @default.
• W2122507029 modified "2023-10-16" @default.
• W2122507029 title "Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis" @default.
• W2122507029 cites W1513592647 @default.
• W2122507029 cites W1820973630 @default.
• W2122507029 cites W1915689252 @default.
• W2122507029 cites W1963848558 @default.
• W2122507029 cites W1967929135 @default.
• W2122507029 cites W1977206110 @default.
• W2122507029 cites W1981661724 @default.
• W2122507029 cites W1986569175 @default.
• W2122507029 cites W1989589268 @default.
• W2122507029 cites W1995386393 @default.
• W2122507029 cites W2021830136 @default.
• W2122507029 cites W2046059252 @default.
• W2122507029 cites W2056377479 @default.
• W2122507029 cites W2061709866 @default.
• W2122507029 cites W2062964758 @default.
• W2122507029 cites W2077409993 @default.
• W2122507029 cites W2085425556 @default.
• W2122507029 cites W2088547651 @default.
• W2122507029 cites W2091943129 @default.
• W2122507029 cites W2104940816 @default.
• W2122507029 cites W2111129843 @default.
• W2122507029 cites W2134753241 @default.
• W2122507029 cites W2149103649 @default.
• W2122507029 cites W2151703174 @default.
• W2122507029 cites W2152348310 @default.
• W2122507029 cites W2159106700 @default.
• W2122507029 cites W2159861616 @default.
• W2122507029 cites W2264636885 @default.
• W2122507029 cites W2413443074 @default.
• W2122507029 cites W60759546 @default.
• W2122507029 doi "https://doi.org/10.1002/art.11181" @default.
• W2122507029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12905467" @default.
• W2122507029 hasPublicationYear "2003" @default.
• W2122507029 type Work @default.
• W2122507029 sameAs 2122507029 @default.
• W2122507029 citedByCount "423" @default.
• W2122507029 countsByYear W21225070292012 @default.
• W2122507029 countsByYear W21225070292013 @default.
• W2122507029 countsByYear W21225070292014 @default.
• W2122507029 countsByYear W21225070292015 @default.
• W2122507029 countsByYear W21225070292016 @default.
• W2122507029 countsByYear W21225070292017 @default.
• W2122507029 countsByYear W21225070292018 @default.
• W2122507029 countsByYear W21225070292019 @default.
• W2122507029 countsByYear W21225070292020 @default.
• W2122507029 countsByYear W21225070292021 @default.
• W2122507029 countsByYear W21225070292022 @default.
• W2122507029 countsByYear W21225070292023 @default.
• W2122507029 crossrefType "journal-article" @default.
• W2122507029 hasAuthorship W2122507029A5014392818 @default.
• W2122507029 hasAuthorship W2122507029A5034270145 @default.
• W2122507029 hasAuthorship W2122507029A5050093551 @default.
• W2122507029 hasAuthorship W2122507029A5051594487 @default.
• W2122507029 hasAuthorship W2122507029A5051697835 @default.
• W2122507029 hasAuthorship W2122507029A5072708850 @default.
• W2122507029 hasAuthorship W2122507029A5082185560 @default.
• W2122507029 hasBestOaLocation W21225070291 @default.
• W2122507029 hasConcept C126322002 @default.
• W2122507029 hasConcept C159654299 @default.
• W2122507029 hasConcept C163764329 @default.
• W2122507029 hasConcept C203014093 @default.
• W2122507029 hasConcept C2776232647 @default.
• W2122507029 hasConcept C2777077863 @default.
• W2122507029 hasConcept C2777575956 @default.
• W2122507029 hasConcept C2777761686 @default.
• W2122507029 hasConcept C2780653079 @default.
• W2122507029 hasConcept C45189115 @default.
• W2122507029 hasConcept C71924100 @default.
• W2122507029 hasConceptScore W2122507029C126322002 @default.
• W2122507029 hasConceptScore W2122507029C159654299 @default.
• W2122507029 hasConceptScore W2122507029C163764329 @default.
• W2122507029 hasConceptScore W2122507029C203014093 @default.
• W2122507029 hasConceptScore W2122507029C2776232647 @default.
• W2122507029 hasConceptScore W2122507029C2777077863 @default.
• W2122507029 hasConceptScore W2122507029C2777575956 @default.
• W2122507029 hasConceptScore W2122507029C2777761686 @default.
• W2122507029 hasConceptScore W2122507029C2780653079 @default.
• W2122507029 hasConceptScore W2122507029C45189115 @default.
• W2122507029 hasConceptScore W2122507029C71924100 @default.
• W2122507029 hasIssue "8" @default.
• W2122507029 hasLocation W21225070291 @default.
• W2122507029 hasLocation W21225070292 @default.
• W2122507029 hasOpenAccess W2122507029 @default.
• W2122507029 hasPrimaryLocation W21225070291 @default.
• W2122507029 hasRelatedWork W152659163 @default.
• W2122507029 hasRelatedWork W2035669487 @default.

• next